Check out $NCNA!
Check out $NuCana(NCNA.US$ ! Under $1.50 a share right now!
Some things to consider:
- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023.
- Total overdue license fees / damages could be about $920 million, and infringement is ongoing at $450 million in EU sales per year.
- A reasonable 6% royalty could lead to a total of $920 million in overdue license fees / damages, and infringement by Gilead still ongoing.
- Cash runway until 2025 and almost 900 patents granted.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
BUY & HODL $NCNA, $LMT, $F, $ADP, $BR, S&P 500, DOW JONES, NASDAQ
153Followers
13Following
305Visitors
Follow